SIAG
PBYI icon

Safeguard Investment Advisory Group’s Puma Biotechnology PBYI Stock Holding History

Safeguard Investment Advisory Group’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-34
Closed – – 511
2020
Q4 		$0 Buy
+34
New +$344 ﹤0.01% 760

Other funds holding PBYI

Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Fred Alger Management
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Safeguard Investment Advisory Group's PBYI Position: Q1 2021 in Review

Safeguard Investment Advisory Group sold out of Puma Biotechnology (PBYI) in Q1 2021, closing a stake of 34 shares.

Safeguard Investment Advisory Group first reported a position in PBYI in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 118 funds tracked by Wall St. Rank hold PBYI as of Q1 2021.

  • Safeguard Investment Advisory Group reported no remaining Puma Biotechnology position as of Q1 2021 after selling out during the quarter.
  • Safeguard Investment Advisory Group sold 34 Puma Biotechnology shares in Q1 2021.
  • Safeguard Investment Advisory Group first reported a position in Puma Biotechnology in Q4 2020 and held it in 1 quarter.
  • Safeguard Investment Advisory Group's Puma Biotechnology position peaked at $0 in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2021.

Based on Safeguard Investment Advisory Group's 13F filing for Q1 2021, filed 10 May 2021.